Ketamine and Prolonged Exposure in PTSD

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

April 3, 2019

Primary Completion Date

November 18, 2019

Study Completion Date

December 4, 2019

Conditions
Post-traumatic Stress Disorder
Interventions
DRUG

ketamine-enhanced prolonged exposure

Subjects will receive a single infusion of racemic ketamine at 0.5mg/kg (ideal body weight) for 40 minutes. The next day, patients will have a standardized prolonged exposure session which lasts approximately 90 minutes. This co-jointed intervention will be repeated for 3 weeks. Then, patients will continue with therapy sessions to complete a total of 10-12 sessions.

Trial Locations (1)

55417

Minneapolis VA Medical Center, Minneapolis

All Listed Sponsors
lead

Minneapolis Veterans Affairs Medical Center

FED

NCT03960658 - Ketamine and Prolonged Exposure in PTSD | Biotech Hunter | Biotech Hunter